New footage emerges showing Khamzat Chimaev ‘punishing’ top UFC contender in impromptu grappling exchange
Join Now for an Exciting New Tongits Game on GameZone!SOMERVILLE, N.J. , Nov. 23, 2024 /PRNewswire/ -- Specified Technologies Inc. has announced their latest Firestop Clash Management (FCM) and Firestop Locator (FSL) releases. FCM automates the process of locating and assigning firestop solutions to conditions within Autodesk ® Revit ® , enabling firestop novices to find firestop solutions like a firestop expert. In this latest release, STI has further expanded the capabilities of FCM by integrating it with their firestop documentation and compliance tool, Firestop Locator (FSL). FSL enables contractors and facilities' teams to document the status, location, and products used for any and all fire life safety services across a building. In the latest update for FSL, teams can now create custom items to track any service on their project beyond the base six (Penetration, Joint, Extinguisher, Door, Damper, and Barrier). Teams can also modify the base six items to include project specific inspection and maintenance requirements and any other details that they would like to be tracked. With this new integration, decisions made during the design phase of a building using FCM are seamlessly passed into FSL during the construction phase, giving implementation teams a jump start on work to be done. This integration also improves data integrity and eliminates the guesswork in the field of determining what firestop systems and products are to be used where. "We're proud of the latest releases of FCM and FSL and look forward to continuing to support the fire life safety community," says Justin Pine, Sr. Manager of Software & Services. Specified Technologies Inc. promotes life and building safety by developing innovative fire protection systems and accompanying digital tools that help stop the spread of fire, smoke, and hot gases. Our SpecSeal® and EZ Path® product lines are engineered for easy installation and deliver powerful performance, often resulting in lower installed costs. Since firestopping is our only business, we concentrate all our resources on providing the highest quality, fully tested, innovative firestopping solutions. Contact: Jess Bern ; jbern@stifirestop.com View original content to download multimedia: https://www.prnewswire.com/news-releases/specified-technologies-inc-unveils-firestop-clash-management-and-locator-updates-302314629.html SOURCE Specified Technologies, Inc.
Grand Opening of Fogão Gaúcho Brazilian SteakhouseEnhabit director Stuart McGuigan purchases $132,150 in stock
SOMERVILLE, N.J. , Nov. 23, 2024 /PRNewswire/ -- Specified Technologies Inc. has announced their latest Firestop Clash Management (FCM) and Firestop Locator (FSL) releases. FCM automates the process of locating and assigning firestop solutions to conditions within Autodesk ® Revit ® , enabling firestop novices to find firestop solutions like a firestop expert. In this latest release, STI has further expanded the capabilities of FCM by integrating it with their firestop documentation and compliance tool, Firestop Locator (FSL). FSL enables contractors and facilities' teams to document the status, location, and products used for any and all fire life safety services across a building. In the latest update for FSL, teams can now create custom items to track any service on their project beyond the base six (Penetration, Joint, Extinguisher, Door, Damper, and Barrier). Teams can also modify the base six items to include project specific inspection and maintenance requirements and any other details that they would like to be tracked. With this new integration, decisions made during the design phase of a building using FCM are seamlessly passed into FSL during the construction phase, giving implementation teams a jump start on work to be done. This integration also improves data integrity and eliminates the guesswork in the field of determining what firestop systems and products are to be used where. "We're proud of the latest releases of FCM and FSL and look forward to continuing to support the fire life safety community," says Justin Pine, Sr. Manager of Software & Services. Specified Technologies Inc. promotes life and building safety by developing innovative fire protection systems and accompanying digital tools that help stop the spread of fire, smoke, and hot gases. Our SpecSeal® and EZ Path® product lines are engineered for easy installation and deliver powerful performance, often resulting in lower installed costs. Since firestopping is our only business, we concentrate all our resources on providing the highest quality, fully tested, innovative firestopping solutions. Contact: Jess Bern ; jbern@stifirestop.com View original content to download multimedia: https://www.prnewswire.com/news-releases/specified-technologies-inc-unveils-firestop-clash-management-and-locator-updates-302314629.html SOURCE Specified Technologies, Inc.
US coach Emma Hayes admits to anthem uncertainty ahead of England stalemateBOZEMAN — Hunter harvest rates in southwestern Montana were mixed during the general deer and elk hunting season, according to data gathered by Montana Fish, Wildlife & Parks biologists. Mild weather during much of the general season made it challenging for hunters to find game at some lower elevations. The general season was held over five weeks and six weekends from Oct. 26 through Dec. 1. During that time, FWP staff operated game check stations at various times and locations in southwest Montana, including stations in Alder, Cameron, Canyon Ferry, Divide, Gallatin Canyon, Silver City and Toston. Collectively, they met with 6,966 hunters who harvested 48 white-tailed deer, 168 mule deer and 406 elk. Biologists use check stations to collect data on hunter participation and success, as well as the species, sex and age class of the animals harvested. Check station data captures a portion of hunting activity on weekends in specific areas. Hunter numbers and harvest rates can be influenced by weather, changes in hunting regulations from one season to another, and other factors. Biologists also rely on information collected through hunter harvest phone surveys each year. The Alder check station was open on the first, third and sixth weekends of the general season. Over those three weekends wildlife staff met with 812 hunters who collectively harvested 16 white-tailed deer, 35 mule deer and 88 elk. The hunter harvest rate for the final weekend was average at 21%, an increase from the 9.7% harvest rate over opening weekend. Biologists operated a check station at Canyon Ferry on the first and final weekends of the general season. They met with 338 hunters who harvested six white-tailed deer, 11 mule deer and 16 elk. Hunter harvest was 3.9% on opening weekend and 8.3% on the final weekend. The Cameron check station was open each weekend during the general season. Wildlife staff there met with 2,935 hunters who harvested 14 white-tailed deer, 60 mule deer and 192 elk over the six weekends. Hunter harvest rates ranged from 6.5% on Nov. 2-3 to 10.6% on Nov. 23-24. Overall harvest numbers were average for elk, above average for mule deer and below average for white-tailed deer. Snow levels were high enough to make high-country travel difficult for hunters, but not enough to concentrate elk on winter ranges. This, combined with above-average numbers of hunters, meant that individual hunter harvest rates in this area were below average. The Divide check station was also open each weekend during the general season. Biologists there met with 1,406 hunters who harvested six white-tailed deer, 43 mule deer and 63 elk over the six weekends. Hunter harvest rates ranged from 6.4% on Nov. 16-17 to 13.4% over the previous weekend. This area also saw relatively mild temperatures and snowfall, with minimal elk movement during the general season. The overall hunter harvest rate at this station was 8.7% this year, up from 7.8% in 2023 but still below the 10-year average of 9.3%. The Gallatin check station operated during the first, second and sixth weekends of the general season. Wildlife staff there met with 500 hunters who harvested one white-tailed deer, five mule deer and 20 elk. Hunter harvest rates ranged from 4.4% over opening weekend to 6.5% the following weekend. Overall, this season had average numbers of hunters and mule deer harvested and below-average numbers of elk harvested. The Silver City check station operated on opening and closing weekends of the general season, with hunter harvest rates of 4.4 and 3%, respectively. Staff met with 902 hunters who harvested one white-tailed deer, eight mule deer and 27 elk over the two weekends. The Toston check station was open on Nov. 9, which brought 73 hunters and a harvest rate of 8.3%. Those hunters harvested six mule deer.
Hurriyat Conference asks Omar-led govt to reinstate employees fired over 'terror links'
The world of gaming is constantly evolving, and innovations in technology continue to push the boundaries of what’s possible. One such exciting possibility is harnessing the power of magnetic fields, which may soon play a crucial role in gaming hardware advancements, thanks to developments in per tesla stock technology . While Tesla Inc. is widely known for its groundbreaking advancements in electric vehicles, its influence extends into the realm of gaming through this concept. Per tesla stock technology involves the utilization of electromagnetic fields, which are measured in Teslas, in new and innovative ways. This technology could potentially revolutionize gaming rigs by providing an unprecedented boost in performance. Imagine modulating your GPU’s capabilities via electromagnetic fields, offering gamers lightning-fast processing speeds and unparalleled graphical fidelity. Such innovations would lead to a new era of immersive gaming experiences—bringing hyper-realistic virtual worlds to life like never before. This transformation is projected to minimize energy consumption, a continual concern in gaming setups, and allows for sleeker designs without sacrificing performance. This change is comparable to moving from internal combustion engines to electric motors in the automotive world. Moreover, the integration of per tesla stock technology may open avenues for game developers to explore new gameplay mechanics. It may usher in an era where physics simulations and AI behaviors become intricately more sophisticated, creating experiences that are not only visually stunning but also deeply engaging. While still in conceptual stages, the developing understanding and embracement of per tesla stock in gaming hint at a thrilling future on the technological horizon. As research progresses, we may very well be on the verge of seeing these theories transform into reality, making your gaming rig a powerhouse of future gaming experiences. Magnetic Fields in Gaming: How Tesla’s Innovations Could Shape the Future The gaming industry stands at the brink of a revolution, thanks to emerging technologies that promise to redefine gaming hardware. Among these is the intriguing concept of harnessing electromagnetic fields through advancements in Tesla’s groundbreaking technology. While Tesla Inc. primarily dominates the electric vehicle sector, its innovations inspire potential breakthroughs in gaming, driving interest and speculation regarding the future of gaming hardware. Pros and Cons of Per Tesla Stock Technology in Gaming Pros: 1. Enhanced Performance : Leveraging electromagnetic fields to optimize GPU functionalities could dramatically boost processing speeds and graphical fidelity, offering more immersive gaming experiences. 2. Energy Efficiency : Just as electric motors have decreased energy consumption in vehicles, this technology may similarly reduce energy usage in gaming setups, addressing longstanding sustainability concerns. 3. Design Innovation : The potential reduction in component size could lead to sleeker, more aesthetically appealing gaming rigs without compromising on power or performance. Cons: 1. Development Costs : Initial research and development investments could be substantial, potentially leading to higher consumer costs upon initial release. 2. Technical Challenges : As with any cutting-edge technology, unforeseen engineering challenges may emerge, requiring additional time and resources to resolve. Predictions and Future Trends The application of electromagnetic technologies is more than a futuristic concept; it indicates a transformative shift akin to the automotive industry’s transition from combustion engines to electric motors. This paradigm shift could lead not only to hardware advancements but also to new frontiers in game design and AI development, fostering gameplay mechanics that are richer and more intricate. As gaming hardware advances, its ripple effects may influence software design, giving rise to innovative physics simulations and AI-driven narratives, pushing the envelope in interactive entertainment. Market Analysis and Compatibility The integration of magnetic field technology remains in its experimental stages, yet it has already piqued the interest of hardware manufacturers seeking competitive advantages. The potential for cross-compatibility with existing gaming systems could determine how swiftly and effectively this innovation penetrates the market. Innovations in Security and Sustainability Security and sustainability remain pivotal. As manufacturers explore these new technologies, strategies to secure electromagnetic systems from potential vulnerabilities will be essential. Furthermore, this technology aligns with sustainable practices, presenting eco-friendly solutions through lower energy requirements and potentially reducing electronic waste by extending the lifespan of gaming rigs. The gaming landscape is poised for dramatic change as technology like per tesla stock becomes more tangible. To learn more about Tesla’s broader spectrum of technological innovations, visit their main website at Tesla .COLLEGE BOWL
Tasmania’s $1 billion salmon industry will supply thousands of Australian households this Christmas, its fresh and smoked fish fillets a relatively cheap alternative to many seafood options. But what is the environmental cost? Salmon farming in Tasmania. Credit: Adam Gibson Tasmania’s big three salmon producers – foreign-owned companies Huon, Tassal and Petuna – promote the industry as sustainable, with low environmental impacts. But the industry’s critics warn it is poorly regulated, environmentally harmful and expanding at an unsustainable pace. Seafood shoppers face a difficult task in deciding who to trust, especially with political leaders gearing up for an election stoush over the future of the industry. Fishy issues Salmon farms have been blamed for environmental degradation around the Tasmanian coastline, antibiotics leaking into the food chain, algal blooms, dead seals and introduction of hundreds of thousands of escapee fish into the environment. However, Salmon Tasmania chief executive Luke Martin, who heads the peak body for the industry, said the farms were a good fit for the Tasmanian environment. “We know millions of Australians will have salmon on the menu this Christmas lunch, and by doing so, they are supporting the livelihoods of 5000 Australians living across regional Tasmanian communities,” Martin said. “Salmon is also a responsibly sourced seafood farmed under the highest environmental regulatory conditions of any farmed protein in Australia. “Aquaculture also eases demand pressure on our wild fishing stocks.” A salmon farm in Tasmania. Credit: Getty Images/iStockphoto Salmon Tasmania’s website states the regulations strike a balance between growing a vital protein source, which is produced with minimal environmental impacts due to careful management. The industry states its physical footprint on the water is 4000 hectares, compared to 426 million for agriculture on land. “Tasmanian waterways are not, and never can be, overrun by salmon pens,” it said. Green gripes However, environmental groups paint a different picture. “The industry puts into the sea more pollutants than all of Tasmania’s sewage outfalls combined,” said Australian Marine Conservation Society sustainable seafood program manager Adrian Meder. The organisation’s GoodFish sustainable seafood guide told shoppers to reject Tasmanian farmed salmon this Christmas, warning that the huge expansion of the industry’s footprint “could lead to high environmental impacts”. Wild fish kilometres from salmon farms have been found with antibiotic residue in their flesh. There are strict health guidelines around food containing antibiotics, due to the potential for uncontrolled use to lead to the creation of so-called superbugs in the human population. Farmed salmon are sometimes treated with antibiotics to prevent infections that can kill fish or hurt production levels. The Salmon Tasmania website said only its veterinarians can prescribe antibiotics. Meder said nutrient-rich salmon waste is churned out from salmon pens, disrupting the marine ecosystem. It has been linked to algal blooms that have, in some instances, clogged inshore reefs in several locations near farms. A Tasmanian parliamentary inquiry completed in 2022 warned that the industry’s rapid growth had been facilitated by the state government, which is “an enthusiastic promoter and supporter of the industry”. It included several scientific expert submissions that warned about algal outbreaks and issued a recommendation for “ceasing operations in sensitive, sheltered and biodiverse areas” – a call Meder said had been ignored. Salmon Tasmania rejected these claims. “We do not know who the Australian Marine Conservation Society is, what their agenda is, or who funds them, but we are very confident in the sustainability of our operations across Tasmania,” Martin said. Harbouring doubts Macquarie Harbour on Tasmania’s west coast is not the main source of salmon supply, producing around 13 per cent of annual production. But it is where the most controversial leases are, because it is the only home for the incredibly rare and ancient relic, the Maugean skate, of which there are only 40 to 120 adults left in the wild. Salmon farming began there in the late 1980s, and all three of Tasmania’s salmon companies, Tassal, Huon and Petuna, operate in the waterway. They have recently scaled back the size of their operations as concerns about the industry’s impact on the critically endangered fish grew. The federal government’s threatened species committee said in August the best way to save the endangered fish was to eliminate, or at least dramatically cut back on, salmon farming in its habitat. The committee said there was a “significant correlation” between low oxygen levels and an increase in salmon farming. Farmed fish suck up a lot of the oxygen in the water, while fish food and faeces that enter the water via the salmon pens feed oxygen-consuming bacteria. Salmon farmers are trialling mechanical systems that push micro bubbles of oxygen to the bottom of the harbour. “No fish farming should ever pose an extinction threat to an endangered species, and no other fish farming industry in Australia does,” Meder said. “It’s actually really easy to do fish farming better than this.” Salmon Tasmania has warned that scaling back the industry could cut the 260 local jobs that it generates and claimed that multiple factors affected water quality, not just farming, including climate change and disruption from hydroelectric dams to river flows into Macquarie Harbour. Political fallout Federal Environment Minister Tanya Plibersek has on her desk a request from environment groups to revoke licences for farming in Macquarie Harbour, but a decision is not expected before an election due by May. Opposition Leader Peter Dutton has accused the government of seeking to shut down the salmon industry. “The government’s prepared to hang the local community out to dry,” he said this month. Macquarie Harbour is in the Braddon electorate, which the Liberal Party won from Labor at the 2019 election. Prime Minister Anthony Albanese has hopes to win Braddon back. He visited on December 14 and declared he would not pre-empt Plibersek’s legal responsibilities as environment minister, but nevertheless guaranteed the industry would continue under his leadership. Prime Minister Anthony Albanese visits salmon farms in Macquarie Harbour, on Tasmania’s west coast. “As long as I’m prime minister, there will be support for jobs here in Tasmania because I understand how important it is for the Tasmanian economy,” Albanese declared. Plibersek was absent from his visit. However, Plibersek said on December 19 that she welcomed the prime minister’s presence in Tasmania and echoed his support for the industry. But it was far harder to interpret her position on the future of the industry, which she said must be weighed against environmental concerns. “We know that the salmon industry is important for local jobs in Tasmania, but we also know that Tasmanians really value their natural environment ... I’m not going to comment on any decision that is before me at the moment.” Cut through the noise of federal politics with news, views and expert analysis. Subscribers can sign up to our weekly Inside Politics newsletter .
What's Going On With Arm Stock Monday?Sam Darnold sensed the backside pressure as soon as he dropped back with Minnesota trailing by four points late in the fourth quarter in Seattle, so he moved into a safe space in the pocket and did precisely what the Vikings would prefer him to do with the game on the line. He threw the ball down the field to Justin Jefferson. The perfectly placed throw near the sideline beat double coverage for a 39-yard touchdown that put the Vikings back in front with 3:51 remaining in a 27-24 victory over the Seahawks on Sunday. “It was a great call,” said Jefferson, who had 10 receptions for 144 yards and two scores, all season highs. “I’m not going to say too much about that play, but something went on where me and Sam were on the same page, and he found me and we went up.” The Vikings were understandably coy about the context around the go-ahead touchdown , when Darnold made a difficult on-the-run pass just over cornerback Tariq Woolen that Jefferson deftly twisted to catch next to his backside hip so he could shield the ball from late-breaking safety Julian Love. Darnold saw Love's shoulders initially shaded inside just enough to believe he couldn't retreat fast enough to prevent Jefferson from getting the ball. Jefferson also applied some improvisation to his route that Darnold clearly and properly read during the play. “I want those guys to have some freedom in those moments,” coach Kevin O'Connell said. “We do a lot of things with Justin and Sam, seeing the coverage and then with some route opportunities to get to at the line of scrimmage, and I think those guys have just gotten so comfortable with that stuff.” Darnold's long-delayed breakout performance under O'Connell has been one of the stories of the NFL this season, one that wouldn't have unfolded as neatly for the third overall pick in the 2018 draft without such synergy between him and his superstar wide receiver. If the Vikings (13-2) win their last two games, they will not only be NFC North champions for the second time in three years but also get the No. 1 seed and the lone first-round bye in the NFC for the playoffs. “Every single game we’re finding different ways to overcome adversity, overcome the different stuff defenses have thrown towards us," Jefferson said. “Sam has done a great job being a leader.” What's working The pass rush was strong, with Andrew Van Ginkel recording two sacks and pressure leading to both interceptions of Seahawks quarterback Geno Smith. The Vikings were credited with eight hits on Smith. What needs help The Vikings converted only three of 12 third downs, their second-worst rate of the season. Stock up Theo Jackson, who saw significant playing time at safety with Harrison Smith out, had the game-sealing interception with 49 seconds left. Stock down Tight end Josh Oliver has played 47% of the snaps the last two games, his two lowest usage rates of the season. He dropped the only pass he was thrown on Sunday. Injury report The defense ought to get a big boost this week with the expected return of the 13-year veteran Smith from his first absence in two years when he was sidelined at Seattle with a foot injury. Linebacker Ivan Pace, who has missed four games on injured reserve with a hamstring strain, is also on track to be back with his return to practice. Backup defensive lineman Jalen Redmond, who didn't play against the Seahawks because of a concussion, has made progress through the protocol, O'Connell said. Backup cornerback Fabian Moreau, who was inactive at Seattle with a hip injury, will continue to be evaluated throughout the week. Key number 13.6% — That's the third-down conversion allowance rate for the Vikings over the last two games, with Chicago and Seattle combining to go just 3 for 22. The Vikings rank second in the NFL in third-down defense at 33.7% for the season and also rank second on fourth down at 36.7%. Up next The Vikings host Green Bay on Sunday, with the kickoff moved to the late afternoon showcase spot on Fox. If Minnesota loses to the Packers, the Lions will clinch the NFC North and the Vikings would open the playoffs on the road as the No. 5 seed at best. Even if the Lions were to lose at San Francisco on Monday night, the Vikings would need to win at Detroit on Jan. 5 to take the division title. AP NFL: https://apnews.com/hub/NFL
Best Stock to Buy Right Now: Amazon vs. Home Depot
NEW YORK , Nov. 22, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global ewing's sarcoma treatment market size is estimated to grow by USD 205.09 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.26% during the forecast period. Growing awareness about and funding for ewings sarcoma is driving market growth, with a trend towards emergence of regenerative therapies. However, lack of approved therapies for ewings sarcoma poses a challenge.Key market players include Actiza Pharmaceutical Pvt. Ltd., Advantech Co. Ltd., Amneal Pharmaceuticals Inc., Baxter International Inc., Bristol Myers Squibb Co., Cellectar Biosciences Inc., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., Fresenius Kabi AG, GlaxoSmithKline Plc, Gradalis Inc., Johnson and Johnson, LGM Pharma LLC, Merck and Co. Inc., Novartis AG, Ocean pharmaceutical, Pfizer Inc., PharmaMar SA, Salvavidas, and UPMC Hillman Cancer Center. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth Ewing sarcoma, a type of bone cancer affecting children and adolescents, is characterized by the activation of the EWS gene on chromosomes 11 and 22. The disease primarily affects the legs, pelvis, chest, and abdomen, causing symptoms like lump formation, fever, bone pain, broken bones, weight loss, paralysis, and bladder loss. Treatment typically involves a combination of chemotherapy drugs such as Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Ifosfamide, and Dactinomycin. Technological advancements have led to the development of pipeline drugs like CDK inhibitors and Regenerative Therapies. Government organizations and healthcare providers continue to invest in disease diagnosis and healthcare spending for approved treatments like Gene Therapy and Disease Diagnosis. Companies like Zydus Cadila and Seqens are leading in this field. Surgery, radiation therapy, and multidrug chemotherapy are common treatment methods. Surgical procedures are performed in hospitals, clinics, and nursing homes, with medical tourism and digital services playing a role in accessibility. The mortality rate for Ewing sarcoma is high, emphasizing the need for continued research and innovation. Symptoms may also affect vital organs like the lungs, heart, kidneys, and skin tissue. The Ewing's sarcoma treatment market has witnessed notable progress in addressing metastatic and recurrent Ewing's sarcoma cases. A cutting-edge approach gaining attention is regenerative medicine, specifically gene therapy. In this method, the patient's mutated gene is extracted and altered in a lab before being reintroduced. The new gene replaces the faulty one. Although no approved gene therapies exist for Ewing's sarcoma, numerous pharmaceutical companies are researching and developing these treatments to combat metastatic and recurrent tumors. Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! Market Challenges Ewing sarcoma, a type of bone cancer affecting children and adolescents, poses significant challenges in treatment due to its aggressive nature and complex genetic makeup. The primary treatment involves multidrug chemotherapy using Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Ifosfamide, and Dactinomycin, which target the activation of the EWS gene on chromosomes 11 and 22. However, the disease's incidence and symptoms, including lump formation, fever, bone pain, broken bones, weight loss, paralysis, and bladder loss, necessitate continuous research and technological advancements. Government organizations and healthcare providers invest heavily in pipeline drugs, such as CDK inhibitors and Regenerative Therapies, to improve disease diagnosis and treatment. Companies like Zydus Cadila and Seqens are developing new therapies, including Gene Therapy and Anti-stathmin therapy, to address recurrent Ewing tissue. The treatment landscape includes surgery, radiation therapy, and chemotherapy in hospitals, clinics, nursing homes, and through medical tourism. Symptoms and vital organ involvement, such as the lungs, heart, kidneys, and skin tissue, require specialized care. The mortality rate underscores the need for continued research and investment in this area. Healthcare spending on Ewing sarcoma treatment is substantial, with diagnostic services, digital services, and surgical procedures being key components. The challenges in treating Ewing sarcoma necessitate a collaborative effort from all stakeholders to improve patient outcomes and quality of life. Ewing's sarcoma is a severe bone and soft tissue cancer primarily affecting adolescents and young adults. The primary tumor is treated with either surgery or radiation, depending on the feasibility of surgical resection. Due to the high risk of metastasis, even in localized cases, chemotherapy is also administered to eliminate microscopic tumors. Chemotherapeutic agents like vincristine, doxorubicin, and cyclophosphamide are commonly used. Although most patients with initially localized Ewing's sarcoma survive long-term, relapse remains a significant issue. There is currently no standard approach to treating relapsed patients. Insights into how AI is reshaping industries and driving growth- Download a Sample Report Segment Overview This ewing's sarcoma treatment market report extensively covers market segmentation by 1.1 Hospitals 1.2 Specialty clinics 1.3 Others 2.1 Combination therapy 2.2 Monotherapy 3.1 North America 3.2 Europe 3.3 Asia 3.4 Rest of World (ROW) 1.1 Hospitals- Hospitals, particularly large and medium-sized institutions, play a significant role in driving the growth of the Ewing's sarcoma treatment market. These hospitals, with over 500 beds, are key end-users due to their high patient volume and purchasing power. They procure therapeutics in large quantities, enabling manufacturers to expand their product reach and enhance brand image. With advanced medical infrastructure and a growing number of emergency department visits due to the increasing incidence of Ewing's sarcoma, sales of treatment therapeutics are expected to rise in these hospitals. Medium-sized hospitals, with around 200-300 beds, also contribute to market expansion. Despite their limited budgets, they engage closely with various stakeholders and have an increasing number of patients, leading to increased demand for Ewing's sarcoma treatment therapeutics. Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022) Research Analysis Ewing sarcoma is a rare and aggressive type of bone cancer that primarily affects children and young adults. It is characterized by the uncontrolled growth of cells in the soft tissues surrounding the bones, often found in the legs, pelvis, chest, and abdomen. The exact cause of Ewing sarcoma is unknown, but it is linked to genetic changes in the EWS gene on chromosomes 11 and 22. The primary treatment for Ewing sarcoma is chemotherapy using drugs such as Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, and Infoposide, as well as Dactinomycin and CDK inhibitors. These drugs target the genetic material and chromosomes of the cancer cells, damaging their ability to divide and grow. The treatment can affect vital organs like the lungs, heart, kidneys, and skin tissue, and may also impact the bone marrow, which can increase the risk of infection and anemia. Age can also be a factor in treatment, as older patients may have different treatment options due to the increased risk of complications. The thigh is a common site for Ewing sarcoma in the legs, and the disease can also occur in the limbs and other bones in the body. Market Research Overview Ewing sarcoma is a rare and aggressive type of bone cancer that affects children and adolescents, typically appearing in the legs, pelvis, chest, and abdomen. The disease is caused by the activation of the EWS gene on chromosomes 11 and 22, leading to the uncontrolled growth of cells. The primary treatment for Ewing sarcoma is multidrug chemotherapy using agents like Vincristine, Cyclophosphamide, Doxorubicin, Etoposide, Ifosfamide, and Dactinomycin. These drugs work by damaging the genetic material of the cancer cells. Technological advancements have led to the development of pipeline drugs and diagnostics, including CDK inhibitors and Regenerative Therapies such as Gene Therapy and Disease Diagnosis. Healthcare spending on Ewing sarcoma treatment is significant, with approved treatments including Surgery, Radiation therapy, and Chemotherapy. Symptoms of Ewing sarcoma include lump formation, fever, bone pain, broken bones, weight loss, paralysis, and bladder loss. Treatment options depend on the location and severity of the disease, with surgical procedures and medical tourism also playing a role. Mortality rate is high for recurrent Ewing tissue, with organizations like Gradalis and Seqens offering anti-stathmin therapy as a potential treatment. The disease can affect various bones, including the thigh, pelvis, and limbs, as well as vital organs such as the lungs, heart, kidneys, and skin tissue. Age is a significant factor in the diagnosis and treatment of Ewing sarcoma, with hospitals and clinics providing essential services to those affected. Nursing homes and digital services also play a role in the care of patients. Overall, the Ewing sarcoma treatment market is continually evolving, with ongoing research and development efforts aimed at improving outcomes for patients. Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation End-user Hospitals Specialty Clinics Others Type Combination Therapy Monotherapy Geography North America Europe Asia Rest Of World (ROW) 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ SOURCE TechnavioMILWAUKEE — Giannis Antetokounmpo had 32 points and 11 rebounds and Damian Lillard added 31 points to lead the Milwaukee Bucks past the Charlotte Hornets 125-119 on Saturday night for their fourth consecutive victory. Milwaukee opened the fourth quarter with a 14-5 spurt for a 110-90 lead, but the Hornets got it to 121-119 on Brandon Miller’s 3-pointer with 15 seconds left. Taurean Prince answered with a pair of free throws for the Bucks to make it a two-possession game, and Charlotte missed a pair of 3-pointers on the ensuing possession. Antetokounmpo hit two free throws with 4.5 seconds left to make it 125-119. LaMelo Ball had a career-high 50 points for the Hornets, and Brandon Miller added 32. Ball hit 17 of 38 shots, including 6 of 17 beyond the arc, and 10 of 13 free throws. Milwaukee, which completed a 4-0 homestand, has won six of its last seven. The only loss in that span was a 115-114 loss to the Hornets on Nov. 16 following a controversial foul call. Charlotte’s Grant Williams went to the locker room late in the fourth quarter with an apparent leg injury and did not return. Takeaways Hornets: Charlotte has lost five of its last seven. Milwaukee Bucks' Bobby Portis reacts in front of Charlotte Hornets' LaMelo Ball during the second half of an NBA basketball game Saturday, Nov. 23, 2024, in Milwaukee. The Bucks won 125-119. Credit: AP/Morry Gash Bucks: Lillard, who did not play in the Bucks' last game against Charlotte, hit 9 of 21 shots, including 10 of 11 free throws. Key moment Milwaukee hit four consecutive 3-pointers for a 12-3 run and a 96-83 lead late in the third quarter. Key stat The Bucks were 18 of 37 from beyond the arc, matching their season high in 3-pointers made. Up next The Hornets host the Orlando Magic on Monday, and the Bucks are at the Miami Heat in NBA Group Play on Tuesday.
Larry Wilson: On climate change, Trump is no King Canute
12 analysts have shared their evaluations of Waters WAT during the recent three months, expressing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 8 2 0 Last 30D 0 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 0 1 5 1 0 3M Ago 1 0 1 1 0 Analysts have recently evaluated Waters and provided 12-month price targets. The average target is $380.83, accompanied by a high estimate of $430.00 and a low estimate of $325.00. This current average reflects an increase of 10.53% from the previous average price target of $344.55. Exploring Analyst Ratings: An In-Depth Overview The standing of Waters among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Sung Ji Nam Scotiabank Announces Sector Perform $430.00 - Derik De Bruin B of A Securities Raises Neutral $430.00 $400.00 Justin Bowers Deutsche Bank Raises Hold $325.00 $310.00 Eve Burstein Bernstein Raises Market Perform $360.00 $345.00 Dan Brennan TD Cowen Raises Hold $410.00 $363.00 Daniel Arias Stifel Raises Hold $360.00 $332.00 Rachel Vatnsdal JP Morgan Raises Neutral $380.00 $340.00 Brandon Couillard Wells Fargo Raises Overweight $415.00 $380.00 Luke Sergott Barclays Raises Underweight $360.00 $330.00 Luke Sergott Barclays Raises Underweight $330.00 $300.00 Tycho Peterson Jefferies Raises Buy $415.00 $355.00 Vijay Kumar Evercore ISI Group Raises In-Line $355.00 $335.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Waters. This offers insight into analysts' perspectives on the current state of the company. Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Waters compared to the broader market. Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Waters's stock. This examination reveals shifts in analysts' expectations over time. Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Waters's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table. Stay up to date on Waters analyst ratings. All You Need to Know About Waters Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions. Financial Insights: Waters Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges. Revenue Growth: Over the 3 months period, Waters showcased positive performance, achieving a revenue growth rate of 4.02% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector. Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 21.82%, the company showcases strong profitability and effective cost control. Return on Equity (ROE): Waters's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.71% ROE, the company effectively utilizes shareholder equity capital. Return on Assets (ROA): Waters's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.6% ROA, the company effectively utilizes its assets for optimal returns. Debt Management: With a high debt-to-equity ratio of 1.19 , Waters faces challenges in effectively managing its debt levels, indicating potential financial strain. The Significance of Analyst Ratings Explained Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter. Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts. Breaking: Wall Street's Next Big Mover Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details . This article was generated by Benzinga's automated content engine and reviewed by an editor. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Putin claims Russia attacked Ukraine with a new missile that the West can't stopMEUDON, Francia--(BUSINESS WIRE)--nov. 21, 2024-- La inteligencia artificial es el tema central de la Cyber Week europea de este año, que tiene lugar entre el 19 y el 21 de noviembre en Rennes (Bretaña). En el marco del desafío organizado por la Agencia de Innovación de Defensa francesa (AID), que coincidirá con la Cyber Week, los equipos de Thales han desarrollado con éxito un metamodelo para detectar imágenes generadas por IA. A medida que el uso de las tecnologías de IA gana terreno, y en una época en que la desinformación es cada vez más frecuente en los medios de comunicación y afecta a todos los sectores de la economía, este metamodelo de detección de «deepfakes» puede ayudar a combatir la manipulación de imágenes en una gran variedad de casos de uso, como la lucha contra la suplantación de identidad. Este comunicado de prensa trata sobre multimedia. Ver la noticia completa aquí: https://www.businesswire.com/news/home/20241120768241/es/ (c)Thales Las imágenes generadas por IA se crean mediante plataformas de IA como Midjourney, Dall-E y Firefly. Se han realizado estudios que demuestran que dentro de unos años el uso de «deepfakes» para el robo y la suplantación de identidad podría causar enormes pérdidas financieras. Gartner estima que es muy probable que en alrededor del 20 % de los ciberataques que se produjeron en 2023 se haya utilizado contenido «deepfake» en distintas campañas de desinformación y manipulación. El informe de Gartner 1 destaca el creciente uso de «deepfakes» en el contexto de fraudes financieros y ataques de phishing sofisticados. “ El metamodelo de detección de «deepfakes» de Thales aborda el problema de la suplantación de identidad y las técnicas de «morphing» ” 2 dijo Christophe Meyer, experto sénior en IA y director de tecnología de cortAIx, el acelerador de IA de Thales . “ Valernos de conjuntos de métodos que utilizan redes neuronales, detección de ruido y análisis de frecuencias espaciales nos ayuda a mejorar la protección del creciente número de soluciones que requieren de verificación de identidad biométrica. Se trata de un avance tecnológico notable que evidencia la gran experiencia de los investigadores de IA de Thales ”. El metamodelo de Thales utiliza técnicas de aprendizaje automático, árboles de decisión y evaluaciones de las fortalezas y debilidades de cada modelo para analizar la autenticidad de las imágenes. El metamodelo combina varios modelos, entre los que se incluyen: El equipo de Thales que está detrás del desarrollo de este metamodelo forma parte de cortAIx, el acelerador de IA del Grupo, que cuenta con más de 600 investigadores e ingenieros de IA, 150 de los cuales se encuentran en el área de investigación y tecnología de Saclay, al sur de París, y trabajan en sistemas de misión crítica. El equipo de hackers éticos ha desarrollado un conjunto de herramientas llamado BattleBox con el propósito de evaluar la solidez de los sistemas basados en IA frente a los ataques diseñados para sacar provecho de los puntos débiles de los distintos modelos de IA (entre los que se incluyen los modelos de lenguaje de gran tamaño), como los ataques adversarios y los intentos de acceder a información sensible. Para contrarrestar estos ataques, el equipo se encarga de desarrollar medidas paliativas avanzadas, como el desaprendizaje, el aprendizaje unificado, las marcas de agua para los modelos y el fortalecimiento de los modelos. En 2023, Thales demostró la experiencia de su equipo durante el desafío CAID (Conferencia sobre Inteligencia Artificial para la Defensa) organizado por la Dirección General de Armamento francesa (DGA), que consistía en el hallazgo de datos de entrenamiento de IA incluso después de que hayan sido borrados del sistema para proteger la confidencialidad. Acerca de Thales Thales (Euronext Paris: HO) es un líder mundial en tecnologías avanzadas especializado en tres áreas empresariales: Defensa y Seguridad, Aeronáutica y Espacio, y Ciberseguridad e Identidad Digital. El Grupo desarrolla productos y soluciones que contribuyen a que el mundo sea un lugar más seguro, más ecológico y más inclusivo. Thales invierte cerca de 4 mil millones de euros al año en Investigación y Desarrollo, especialmente en áreas claves para la innovación como la IA, la ciberseguridad, la tecnología cuántica, las tecnologías de computación en la nube y la tecnología 6G. Thales cuenta con 81 000 empleados en 68 países. En 2023, el Grupo generó ventas valuadas en 18 400 millones de euros. VISITE Grupo Thales Defensa Thales Desarrollamos sistemas de IA de confianza | Grupo Thales 1 Informe Gartner de 2023 sobre Riesgos Emergentes de Ciberseguridad. 2 El «morphing» consiste en transformar gradualmente un rostro en otro en etapas sucesivas mediante la modificación de los rasgos visuales para crear una imagen realista que combine elementos de ambos rostros. El resultado final es una combinación de las dos imágenes originales. El texto original en el idioma fuente de este comunicado es la versión oficial autorizada. Las traducciones solo se suministran como adaptación y deben cotejarse con el texto en el idioma fuente, que es la única versión del texto que tendrá un efecto legal. Vea la versión original en businesswire.com : https://www.businesswire.com/news/home/20241120768241/es/ CONTACT: Marion Bonnet Directora de Relaciones Públicas de Thales Marion.bonnet@thalesgroup.com +33660384892 KEYWORD: FRANCE EUROPE INDUSTRY KEYWORD: APPS/APPLICATIONS ONLINE PRIVACY TECHNOLOGY SECURITY OTHER TECHNOLOGY SOFTWARE NETWORKS INTERNET DATA MANAGEMENT ARTIFICIAL INTELLIGENCE SOURCE: Thales Copyright Business Wire 2024. PUB: 11/21/2024 06:42 PM/DISC: 11/21/2024 06:40 PM http://www.businesswire.com/news/home/20241120768241/es